Two Sigma Advisers’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-50
Closed -$198K 2739
2022
Q3
$198K Sell
50
-105
-68% -$416K ﹤0.01% 2205
2022
Q2
$405K Sell
155
-139
-47% -$363K ﹤0.01% 2009
2022
Q1
$944K Sell
294
-89
-23% -$286K ﹤0.01% 1669
2021
Q4
$2.4M Sell
383
-78
-17% -$489K 0.01% 1101
2021
Q3
$4.27M Buy
461
+210
+84% +$1.94M 0.01% 865
2021
Q2
$2.54M Buy
+251
New +$2.54M 0.01% 1180
2021
Q1
Sell
-8
Closed -$49K 2761
2020
Q4
$49K Sell
8
-22
-73% -$135K ﹤0.01% 2322
2020
Q3
$109K Buy
+30
New +$109K ﹤0.01% 2267